Skip to main content
MRVI logo

MRVI · Maravai Lifesciences Holdings, Inc.

$6.76 -0.29 (-4.11%) At close · Jul 24
Market Cap
$1.75B
Shares
258.19M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Bernd Brust $10,129,708
William E. Martin III $3,845,263
Raj Asarpota $3,506,793
Peter Leddy $1,849,804
Kevin Herde $1,730,738
Kurt Oreshack $1,470,977
Christine Dolan $1,454,198
Fiscal 2024
Executive Total
William Martin $6,380,399
William E. Martin III $6,380,399
Andrew Burch $2,558,244
Rebecca Buzzeo $2,459,680
Peter Leddy $2,363,764
Kevin Herde $2,339,364
Fiscal 2023
Executive Total
Carl Hull $5,217,013
Andrew Burch $2,992,807
Peter Leddy $2,827,776
Kevin Herde $2,793,002
William E. Martin III $2,301,864
William Martin $2,301,864
Christine Dolan $2,263,082
Fiscal 2022
Executive Total
William Martin $14,523,493
Carl Hull $5,480,801
Peter Leddy $3,923,498
Kevin Herde $1,741,482
Christine Dolan $1,594,953
Fiscal 2021
Executive Total
Carl Hull $1,780,769
Christine Dolan $844,670
Kevin Herde $841,598
Fiscal 2020
Executive Total
Carl Hull $2,124,160
Eric Tardif $1,896,348
Brian Neel $1,861,262
Fiscal 2019
Executive Total
Carl Hull $2,828,417
Brian Neel $893,509
Key facts CIK 1823239 CUSIP 56600D107 13F (30d) 16 filings 16 filers Visit website Investor relations